Liver microwave ablation: a systematic review of various FDA-approved systemsRuiter, S. J. S., Heerink, W. J. & de Jong, K. P., Aug-2019, In : European Radiology. 29, 8, p. 4026-4035 10 p.
Research output: Contribution to journal › Review article › Academic › peer-review
ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p
|Number of pages||10|
|Early online date||30-Nov-2018|
|Publication status||Published - Aug-2019|
- Microwaves, Ablation techniques, Electromagnetic radiation, Tumor volume, Liver diseases, EX-VIVO BOVINE, VENOUS-BLOOD FLOW, IN-VIVO, THERMOSPHERE ABLATION, HEPATOCELLULAR-CARCINOMA, RADIOFREQUENCY ABLATION, REPORTING CRITERIA, THERMAL ABLATION, DEVICES, ENERGY